Brooks Laboratories informs about business updates

15 Sep 2015 Evaluate

Brooks Laboratories has informed that as per SEBI website, the Whole Time member has passed an Order dated September 10, 2015 against the Company and its directors / officials. As per the Order, the Company, its three directors and two former officials of the Company are prohibited from raising any further capital from the securities market, in any manner, for a period of 5 years starting from December 28, 2011. Further, as per the said Order the Company is permitted to utilize the funds lying in the escrow account for the objects disclosed in the Prospectus. They have yet not been served with the copy of the said Order by post. They may point out that the Order is culmination of the Ad-Interim Ex-Parte Order passed against the Company on December 28, 2011 and a subsequent Confirmatory Order in this regard on July 09, 2013, which are already in public domain. They would like to submit that they do not agree with the findings of the Order and they would be contesting the same before Securities Appellate Tribunal in due course.

The above information is a part of company’s filings submitted to BSE.

Brooks Laboratories Share Price

165.50 3.20 (1.97%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.